3-nitropropionic acid and caffeine

3-nitropropionic acid has been researched along with caffeine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Chen, JF; Ferrante, RJ; Fink, JS; Kalda, A; Ryu, H; Schwarzschild, MA; Stack, EC1
Aragon, CM; Manrique, HM; Miquel, M1
Aubrecht, J; Chen, R; Fornace, AJ; Heard, P; Hyduke, DR; Li, HH; Yauk, CL1

Other Studies

4 other study(ies) available for 3-nitropropionic acid and caffeine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage.
    Journal of neurochemistry, 2004, Volume: 88, Issue:3

    Topics: Adenosine A2 Receptor Antagonists; Animals; Caffeine; Corpus Striatum; Female; Gene Silencing; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitro Compounds; Propionates; Receptor, Adenosine A2A

2004
Acute administration of 3-nitropropionic acid, a reactive oxygen species generator, boosts ethanol-induced locomotor stimulation. New support for the role of brain catalase in the behavioural effects of ethanol.
    Neuropharmacology, 2006, Volume: 51, Issue:7-8

    Topics: Acetaldehyde; Amitrole; Animals; Brain Chemistry; Caffeine; Carnitine; Catalase; Drug Synergism; Energy Metabolism; Ethanol; Hydrogen Peroxide; Locomotion; Male; Mice; Models, Neurological; Motor Activity; Nitro Compounds; Oxidants; Oxidation-Reduction; Propionates; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate

2006
Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells.
    Environmental and molecular mutagenesis, 2015, Volume: 56, Issue:6

    Topics: Activating Transcription Factor 3; Caffeine; Cell Cycle Proteins; Cell Line; Cluster Analysis; Cyclin-Dependent Kinase Inhibitor p21; Databases, Genetic; Dose-Response Relationship, Drug; Gene Expression Profiling; Genetic Markers; Humans; Mesylates; Mutagenicity Tests; Nitro Compounds; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Propionates; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Risk Assessment; Toxicogenetics

2015